BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 34918856)

  • 1. Current attitude to deferral of cellular therapy or nontransplant chemotherapy due to SARS-CoV-2 asymptomatic infection: Survey of Infectious Diseases Working Party EBMT.
    Styczynski J; Cesaro S; von Lilienfeld-Toal M; Marchesi F; Gil L; Mikulska M; Knelange N; Wendel L; Averbuch D; de la Camara R
    Transpl Infect Dis; 2022 Apr; 24(2):e13773. PubMed ID: 34918856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for a severe disease course in children with SARS-COV-2 infection following hematopoietic cell transplantation in the pre-Omicron period: a prospective multinational Infectious Disease Working Party from the European Society for Blood and Marrow Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) study.
    Averbuch D; de la Camara R; Tridello G; Knelange NS; Bykova TA; Ifversen M; Dobsinska V; Ayas M; Hamidieh AA; Pichler H; Perez-Martinez A; Cesaro S; Sundin M; Badell I; Bader P; Johansson JE; Mirci-Danicar O; Sedlacek P; Paillard C; Gibson B; Lawson S; Kroeger N; Corbacioglu S; Mikulska M; Piñana JL; Styczynski J; Ljungman P
    Bone Marrow Transplant; 2023 May; 58(5):558-566. PubMed ID: 36849806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic cell transplantation and cellular therapies in Europe 2021. The second year of the SARS-CoV-2 pandemic. A Report from the EBMT Activity Survey.
    Passweg JR; Baldomero H; Ciceri F; Corbacioglu S; de la Cámara R; Dolstra H; Glass B; Greco R; McLornan DP; Neven B; de Latour RP; Perić Z; Ruggeri A; Snowden JA; Sureda A
    Bone Marrow Transplant; 2023 Jun; 58(6):647-658. PubMed ID: 36879108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves.
    Nawas MT; Shah GL; Feldman DR; Ruiz JD; Robilotti EV; Aslam AA; Dundas M; Kamboj M; Barker JN; Cho C; Chung DJ; Dahi PB; Giralt SA; Gyurkocza B; Lahoud OB; Landau HJ; Lin RJ; Mailankody S; Palomba ML; Papadopoulos EB; Politikos I; Ponce DM; Sauter CS; Shaffer BC; Scordo M; van den Brink MRM; Perales MA; Tamari R
    Transplant Cell Ther; 2021 May; 27(5):438.e1-438.e6. PubMed ID: 33728417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report.
    Madduri D; Parekh S; Campbell TB; Neumann F; Petrocca F; Jagannath S
    J Med Case Rep; 2021 Feb; 15(1):90. PubMed ID: 33608053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection.
    Nimgaonkar I; Yoke LH; Roychoudhury P; Flaherty PW; Oshima MU; Weixler A; Gauthier J; Greninger AL; Mielcarek M; Boeckh M; Liu C; Hill JA
    Clin Infect Dis; 2024 Mar; ():. PubMed ID: 38427848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infections in cancer outpatients-Most infected patients are asymptomatic carriers without impact on chemotherapy.
    Hempel L; Piehler A; Pfaffl MW; Molnar J; Kirchner B; Robert S; Veloso J; Gandorfer B; Trepotec Z; Mederle S; Keim S; Milani V; Ebner F; Schweneker K; Fleischmann B; Kleespies A; Scheiber J; Hempel D; Zehn D
    Cancer Med; 2020 Nov; 9(21):8020-8028. PubMed ID: 33022856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Infection in the Pediatric Oncology Population: The Definitive Comprehensive Report of the Infectious Diseases Working Group of AIEOP.
    Zama D; Zanaroli A; Corbelli A; Lo Vecchio A; Del Bene M; Colombini A; Compagno F; Barone A; Fontanili I; Rosaria D'Amico M; Papa MR; Petris MG; Calore E; Montalto S; Meneghello L; Brescia L; Mura R; La Spina M; Muggeo P; Rinieri S; Meazza C; Perruccio K; Cellini M; Spadea M; Mercolini F; Petroni V; De Santis R; Soncini E; Provenzi M; Giurici N; Ziino O; Tridello G; Cesaro S
    J Infect Dis; 2024 Apr; 229(4):1050-1058. PubMed ID: 37962869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP).
    Worel N; Ljungman P; Verheggen ICM; Hoogenboom JD; Knelange NS; Eikema DJ; Sánchez-Ortega I; Riillo C; Centorrino I; Averbuch D; Chabannon C; de la Camara R; Kuball J; Ruggeri A
    Bone Marrow Transplant; 2023 Dec; 58(12):1348-1356. PubMed ID: 37673982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Prevalence of Asymptomatic COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.
    Clarke C; Prendecki M; Dhutia A; Ali MA; Sajjad H; Shivakumar O; Lightstone L; Kelleher P; Pickering MC; Thomas D; Charif R; Griffith M; McAdoo SP; Willicombe M
    J Am Soc Nephrol; 2020 Sep; 31(9):1969-1975. PubMed ID: 32732391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the impact of SARS-COV-2 on delivery of CAR T-cell therapy in Europe: a retrospective survey from the CTIWP of the EBMT.
    Ghorashian S; Malard F; Yüksel MK; Mauff K; Hoogenboom JD; Urbano-Ispizua A; Kuball J; de la Camara R; Ljungman P; Ruggeri A; Chabannon C
    Bone Marrow Transplant; 2022 Feb; 57(2):299-301. PubMed ID: 34802048
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful outcome of pre-engraftment COVID-19 in an HCT patient: impact of targeted therapies and cellular immunity.
    Pourhassan H; La Rosa C; Chiuppesi F; Puing A; Aldoss I; Park Y; Zhou Q; Karpinski V; Faircloth K; Kaltcheva T; Johnson D; Francisco SO; Zaia JA; Nakamura R; Al Malki MM; Diamond DJ; Dadwal SS; Forman SJ
    Blood Adv; 2022 Mar; 6(6):1645-1650. PubMed ID: 35008104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study.
    Yassa M; Yirmibes C; Cavusoglu G; Eksi H; Dogu C; Usta C; Mutlu M; Birol P; Gulumser C; Tug N
    J Matern Fetal Neonatal Med; 2020 Nov; 33(22):3820-3826. PubMed ID: 32691641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of SARS-CoV-2 RNA in nasopharyngeal swabs from COVID-19 patients and asymptomatic cases of infection by real-time and digital PCR.
    Ternovoi VA; Lutkovsky RY; Ponomareva EP; Gladysheva AV; Chub EV; Tupota NL; Smirnova AM; Nazarenko AA; Loktev VB; Gavrilova EV; Agafonov AP; Maksyutov RA
    Klin Lab Diagn; 2020 Dec; 65(12):785-792. PubMed ID: 33373511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal, fetal and neonatal outcomes of large series of SARS-CoV-2 positive pregnancies in peripartum period: A single-center prospective comparative study.
    Hcini N; Maamri F; Picone O; Carod JF; Lambert V; Mathieu M; Carles G; Pomar L
    Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():11-18. PubMed ID: 33310656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Cabrera Villegas A; Romero Robles LG; Boulvard Chollet XLE; Albornoz Almada MC; Mangas Losada M; Garrastachu P; Cañete Sánchez FM; Ramírez Lasanta R; Delgado Bolton RC
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):786-793. PubMed ID: 32936372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinated and Convalescent Donor-Derived Severe Acute Respiratory Syndrome Coronavirus 2-Specific T Cells as Adoptive Immunotherapy for High-Risk Coronavirus Disease 2019 Patients.
    Papayanni PG; Chasiotis D; Koukoulias K; Georgakopoulou A; Iatrou A; Gavriilaki E; Giannaki C; Bitzani M; Geka E; Tasioudis P; Chloros D; Fylaktou A; Kioumis I; Triantafyllidou M; Dimou-Besikli S; Karavalakis G; Boutou AK; Siotou E; Anagnostopoulos A; Papadopoulou A; Yannaki E
    Clin Infect Dis; 2021 Dec; 73(11):2073-2082. PubMed ID: 33905481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.